-
Industry analysts are skeptical that Federal Trade Commission Chair Lina Khan can win her first fight against a drug industry merger. It will be reviewed by a judge appointed by President Donald Trump.
-
The president has directed the FTC to carefully consider health industry mergers that may stymie competition and drive up prices.
-
According to authorities, a huge surge in fraud cases targeting seniors and other vulnerable populations affected by the pandemic has been reported.
-
Former Orlando Health patients may have to help repay the Centers for Medicare and Medicaid Services after a federal audit discovered the hospital…
-
The Federal Trade Commission announced Wednesday that it will approve the sale of the troubled Naples-based hospital chain Health Management Associates if…
-
Scam artists are using the public’s confusion over the Affordable Care Act to obtain information and sell phony products through phone and mail, McClatchy…
-
The ruling may end the era of what are also called "reverse-payment" deals, in which the maker of a brand-name drug pays a maker of generic drugs to not produce a lower-priced version of their product. The Federal Trade Commission can challenge such deals in court, the justices say.